Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Vanda Pharmaceuticals Inc. | Financial_Report.xls |
| 10-K - FORM 10-K - Vanda Pharmaceuticals Inc. | d294468d10k.htm |
| EX-31.2 - EX-31.2 - Vanda Pharmaceuticals Inc. | d294468dex312.htm |
| EX-32.2 - EX-32.2 - Vanda Pharmaceuticals Inc. | d294468dex322.htm |
| EX-31.1 - EX-31.1 - Vanda Pharmaceuticals Inc. | d294468dex311.htm |
| EX-10.44 - EX-10.44 - Vanda Pharmaceuticals Inc. | d294468dex1044.htm |
| EX-10.43 - EX-10.43 - Vanda Pharmaceuticals Inc. | d294468dex1043.htm |
| EX-10.45 - EX-10.45 - Vanda Pharmaceuticals Inc. | d294468dex1045.htm |
| EX-32.1 - EX32.1 - Vanda Pharmaceuticals Inc. | d294468dex321.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-133368, No. 333-138070, No. 333-141571, No. 333-148924, No. 333-156995, No. 333-164567, No. 333-171962 and No. 333-179265) and on Form S-3 (No. 333-171963) of Vanda Pharmaceuticals Inc. of our report dated March 9, 2012 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Baltimore, Maryland
March 9, 2012